Skip Navigation

Cardiovascular Research 2007 76(1):149-159; doi:10.1016/j.cardiores.2007.06.002
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Nimmegeers, S.
Right arrow Articles by Van de Voorde, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nimmegeers, S.
Right arrow Articles by Van de Voorde, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2007, European Society of Cardiology

Functional role of the soluble guanylyl cyclase {alpha}1 subunit in vascular smooth muscle relaxation

Sofie Nimmegeersa, Patrick Sipsb,c, Emmanuel Buysb,c,d, Peter Brouckaertb,c and Johan Van de Voordea,*

aDepartment of Physiology and Physiopathology, Ghent University, Ghent, Belgium
bDepartment for Molecular Biomedical Research, Flanders Interuniversity Institute for Biotechnology (VIB), Ghent, Belgium
cDepartment of Molecular Biology, Ghent University, Ghent, Belgium
dCardiovascular Research Center, Massachusetts General Hospital, 149, 13th street, Charlestown, MA 02129, United States

*Corresponding author. Department of Physiology and Physiopathology, De Pintelaan 185, 9000 Ghent, Belgium. Tel.: +32 9 240 33 42; fax: +32 9 240 30 59. johan.vandevoorde{at}UGent.be

Objective Soluble guanylyl cyclase (sGC), the predominant receptor for nitric oxide (NO), exists in 2 active isoforms ({alpha}2β1 and {alpha}1β1). In vascular tissue sGC{alpha}1β1 is believed to be the most important. The aim of our study was to investigate the functional importance of the sGC{alpha}1-subunit in vasorelaxation.

Methods Aortic and femoral artery segments from male and/or female sGC{alpha}1–/– mice and wild-type littermates were mounted in a small-vessel myograph for isometric tension recording. This was supplemented with biochemical measurements of the cGMP concentration and sGC enzyme activity.

Results The functional importance of sGC{alpha}1β1 was demonstrated by the significantly decreased relaxing effects of acetylcholine (ACh), sodium nitroprusside (SNP), S-nitroso-N-acetylpenicillamine (SNAP), NO gas, YC-1, BAY 41-2272 and T-1032 in the sGC{alpha}1–/– mice of both genders. Moreover, the basal and SNP-stimulated cGMP levels and basal sGC activity were significantly lower in the sGC{alpha}1–/– mice. However, the relaxing effects of NO, BAY 41-2272 and YC-1 seen in blood vessels from sGC{alpha}1–/– mice indicate a role for an sGC{alpha}1β1-independent mechanism. The increase in sGC activity after addition of BAY 41-2272 and the inhibition of the ACh-, SNP-, SNAP- and NO gas-induced response by the sGC inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) in the sGC{alpha}1–/– mice are observations suggesting that the sGC{alpha}2β1 isoform is also functionally active. However, the insignificant increase in cGMP in response to SNP and the non-upregulated sGC{alpha}2 expression level in the sGC{alpha}1–/– mice suggest rather the involvement of (an) sGC-independent mechanism(s).

Conclusions We conclude that sGC{alpha}1β1 is involved in the vasorelaxation induced by NO-dependent and NO-independent sGC activators in both genders. However, the remaining relaxation seen in the sGC{alpha}1–/– mice suggests that besides sGC{alpha}1β1 also the minor isoform sGC{alpha}2β1 and/or (an) sGC-independent mechanism(s) play(s) a substantial role.

KEYWORDS Arteries; Nitric oxide; Endothelial function; Second messengers; Vasoconstriction/dilatation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Zhou, A. Pyriochou, A. Kotanidou, G. Dalkas, M. van Eickels, G. Spyroulias, C. Roussos, and A. Papapetropoulos
Soluble guanylyl cyclase activation by HMR-1766 (ataciguat) in cells exposed to oxidative stress
Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1763 - H1771.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. S. Buys, P. Sips, P. Vermeersch, M. J. Raher, E. Rogge, F. Ichinose, M. Dewerchin, K. D. Bloch, S. Janssens, and P. Brouckaert
Gender-specific hypertension and responsiveness to nitric oxide in sGC{alpha}1 knockout mice
Cardiovasc Res, July 1, 2008; 79(1): 179 - 186.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. G. Sharina, F. Jelen, E. P. Bogatenkova, A. Thomas, E. Martin, and F. Murad
{alpha}1 Soluble Guanylyl Cyclase (sGC) Splice Forms as Potential Regulators of Human sGC Activity
J. Biol. Chem., May 30, 2008; 283(22): 15104 - 15113.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
G. Vanneste, I. Dhaese, P. Sips, E. Buys, P. Brouckaert, and R. A. Lefebvre
Gastric motility in soluble guanylate cyclase {alpha}1 knock-out mice
J. Physiol., November 1, 2007; 584(3): 907 - 920.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.